Hypera (BSP:HYPE3) YoY EBITDA Growth : 14.26% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Hypera YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Hypera's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 14.26%.

Hypera's EBITDA per Share for the three months ended in Mar. 2024 was R$1.10.

Hypera YoY EBITDA Growth Historical Data

The historical data trend for Hypera's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera YoY EBITDA Growth Chart

Hypera Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-7.49

22.23

39.98

28.09

4.23

Hypera Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															16.91	14.47	11.16	-20.51	14.26

Hypera YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Hypera's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(4.511	-	4.328)	/	\| 4.328 \|
=	4.23 %

Hypera's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(1.098	-	0.961)	/	\| 0.961 \|
=	14.26 %

Hypera YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Hypera's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Hypera (BSP:HYPE3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (BSP:HYPE3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

HYPMY:USA HM6A:Germany

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.

Hypera (BSP:HYPE3) Headlines

No Headlines